85 related articles for article (PubMed ID: 299757)
1. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
McMaster R; Buhler K; Whitney R; Levy JG
J Immunol; 1977 Jan; 118(1):218-22. PubMed ID: 299757
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
McMaster R; Buhler K; Whitney R; Levy JG
J Immunol; 1977 Jan; 118(1):223-5. PubMed ID: 830748
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
[TBL] [Abstract][Full Text] [Related]
4. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
Ishizaka K; Adachi T
J Immunol; 1976 Jul; 117(1):40-7. PubMed ID: 1084370
[TBL] [Abstract][Full Text] [Related]
5. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
Gautam SC; Deodhar SD
Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
[TBL] [Abstract][Full Text] [Related]
6. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
7. Immunological activity of regional lymph nodes in tumor-bearing mice.
Barna BP; Deodhar SD
Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
[TBL] [Abstract][Full Text] [Related]
8. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
9. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
Fujimoto S; Greene MI; Sehon AH
J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
[TBL] [Abstract][Full Text] [Related]
10. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the responding populations for the generation of proliferative response to syngeneic Meth A tumor in BALB/c mice: requirement of T and B cell collaboration.
Ting CC; Rodrigues D; Hong JX
J Immunol; 1980 Dec; 125(6):2742-8. PubMed ID: 6968794
[TBL] [Abstract][Full Text] [Related]
12. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
Harada M; Pearson G; Redmon L; Winters E; Kasuga S
J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
[TBL] [Abstract][Full Text] [Related]
13. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
[TBL] [Abstract][Full Text] [Related]
14. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
16. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
Dennert G; Hatlen LE; Tucker DF
J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.
Flood PM; Murphy DB; Horowitz M; LeClair KP; Smith FR; Stockert E; Palladino MA; DeLeo AB
J Immunol; 1985 Jul; 135(1):63-72. PubMed ID: 2987354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
